Viatris Healthcare

Viatris is a global healthcare company formed in 2020 through the combination of Mylan and Pfizer's Upjohn business. The company maintains a vast portfolio of best-in-class iconic brand-name products, generics, complex generics, and biosimilars across a wide range of therapeutic areas. Viatris operates a massive global manufacturing and supply chain network, providing medicines to patients in more than 165 countries and territories. Its business model focuses on expanding access to affordable, high-quality medicines while investing in a pipeline of complex products and novel therapies. The company is headquartered in the United States and maintains significant operations in Europe and Asia.